Public joins together for Community Gathering after fatal shooting at Brown University Providence City Council is inviting members of the public to a Community Gathering on Sunday to share support for ...

The FDA has approved the expanded use of Botox® (onabotulinumtoxinA; Allergan) for the treatment of spasticity in pediatric patients aged ≥2 years, including those with lower limb spasticity caused by ...

Many stroke patients suffer from spasticity of the arm that cause pain and impaired sensorimotor function. But there are ways of identifying such patients ahead of time so that they can obtain the ...

Final results from a multi-center study shows that repeated treatments of botulinum toxin type A (BoNTA or Botox) over one year is well tolerated and results in a significant decrease in spasticity, ...

Spasticity is a condition that causes muscle stiffness and affects a person’s ability to speak and move. A variety of different treatment options are available to help manage this condition.

The FDA has approved Botox for the treatment of lower limb spasticity in pediatric patients 2 to 17 years of age, excluding spasticity caused by cerebral palsy. The treatment was already approved for ...

FDA approved an expanded Botox label, which now includes eight new muscles to treat adults with upper limb spasticity. On July 29, 2021, Allergan, an AbbVie company, announced that FDA approved a ...

Ipsen (GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen recently completed a study titled A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, ...

Final results from a multi-center study shows that repeated treatments of botulinum toxin type A over one year is well tolerated and results in a significant decrease in spasticity Final results from ...

Arbaclofen extended-release (ER) reduced spasticity in patients with multiple sclerosis and was found to be safe and well-tolerated, according to 2 new abstracts presented at the 33rd Annual Meeting ...